10,000 results
·
144ms
·
Sources: EU EUDAMED, US FDA
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·SPECTRANETICS CORONARY ATHERECTOMY (ELCA) CATHETERS
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·AIS EXIMER LASER ANGIOPLASTY
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-Ll (SP142) Assay
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1 (SP263) Assay
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-Ll (SP142) Assay
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1(SP142) Assay
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·SPECTRANECTICS CVX-300 EXCIMER LASER SYSTEM
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1 (SP263) Assay
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·CVX-300 Excimer Laser System
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·ELCA CORONARY ATHERECTOMY CATHETERS
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·ELCA CORONARY ATHERECTOMY CATHETERS
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·ELCA Coronary Laser Atherectomy Catheters
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·CVX-300 and CVX-300-P Excimer Laser Systems
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·CVX-300/CVX300-P EXCIMER LASER SYSTEM
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·SPECTRANETICS EXCIMER LASER
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·EXCIMER LASER
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·8 ECTRAPROBE-PLR MODEL 900 OPTILASE CONTACT LASER
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 pharmDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 PHARMDX (Melanoma Indication)
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·CVX-300 LASER SYSTEM